The National Cancer Institute created network of clinical proteomic technology centers for cancer research
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved for use in the treatment of women…
On Jun. 30, 2006, Genentech drug Lucentisル (ranibizumab injection) was approved by the FDA for the treatment of…
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…
On Jun. 29, 2006, the Immunization Practices Advisory Committee (ACIP) recommends second dose of varicella vaccine for children.
On Jun. 27, 2006, the U.S. Surgeon General released a report on the harmful health consequences of involuntary…
On Jun. 8, 2006, the FDA approved the vaccine Gardasil, which protects against persistent infection by the two…
Washington BioEvolution illustrates life science companies and non-profit research organization in the State of Washington by the year…
On May 25, 2006, Zostavax, manufactured by Merck & Co. of Whitehouse Station, New Jersey, was approved by…
On May 18, 2006, the U.S. Centers for Disease Control and Prevention (CDC) resported on a multi-state mumps…
On May 16, 2006, Siemens, now Sivantos, launched Centra, the world’s first in-office digital earmold impression scanner. The…
On May 1, 2006, Dr. Stephen Prescott was named president of the Oklahoma Medical Research Foundation (OMRF). Prescott,…
On Apr. 12, 2006, chemical engineer Jay Keasling helped create an affordable anti-malaria drug, artemensins, by producing arteminsic…
On Mar. 27, 2006, The Priestley Medal was awarded to Paul S. Anderson by the American Chemical Society…
On Feb. 24, 2006, the Advisory Committee on Immunization Practices (ACIP) was informed by the only U.S.-licensed manufacturer…
On Oct. 17, 2005, the FDA approved lowering the age limit to 12 mos for the remaining U.S.-licensed…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
On Sept. 28, 2005, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke (NINDS)…
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
On Aug. 18, 2005, the Medically Fragile Children’s Program was established at the Medical University of South Carolina….
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
On Apr. 29, 2005, Amylin Pharmaceuticals and Eli Lilly announced the FDA had approved BYETTA(TM) (exenatide) injection as…
On Mar. 7, 2005, the CDC commissioned the Nebraska Biocontainment Unit at UNMC. The funding came from federal…
On Feb. 16, 2005, in preparation for the new generation of molecular-based oncology medical products, the National Cancer…
On Feb. 16, 2005, Formation of the Drug Safety Board was announced, consisting of FDA staff and representatives…
On Jan. 8, 2005, researchers from Baylor University Medical Center reported that although the origin of smallpox is…
In Jan. 2005, the Institute for Translational Medicine and Therapeutics (ITMAT) was established at Penn’s Perelman School of…